Amundi Index Solutions - Amundi Index Equity Global Multi Smart Allocation Scientific Beta AE-C EURRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 2.8 | 20.1 | -4.0 | 7.0 | 7.8 | |
+/-Cat | -11.5 | 5.1 | 5.8 | -2.5 | 1.9 | |
+/-B’mrk | -9.7 | 1.1 | 4.1 | -7.7 | -0.9 | |
Category: Global Flex-Cap Equity | ||||||
Category Benchmark: Morningstar Gbl All Cap TME... |
Key Stats | ||
NAV 25/04/2024 | EUR 139.66 | |
Day Change | -0.89% | |
Morningstar Category™ | Global Flex-Cap Equity | |
ISIN | LU1437019307 | |
Fund Size (Mil) 25/04/2024 | EUR 36.20 | |
Share Class Size (Mil) 25/04/2024 | EUR 0.15 | |
Max Initial Charge | 4.50% | |
Ongoing Charge 11/02/2022 | 0.50% |
Investment Objective: Amundi Index Solutions - Amundi Index Equity Global Multi Smart Allocation Scientific Beta AE-C EUR |
To track the performance of Scientific Beta Developed Multi-Beta Multi-Strategy Four-Factor ERC Index ("the Index"), and to minimize the tracking error between the net asset value of the sub-fund and the performance of the Index. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Nobuaki Kato 05/01/2017 | ||
Inception Date 05/06/2017 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
Scientific Beta Dev MB MS F-F ERC NR EUR | Morningstar Gbl All Cap TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Amundi Index Solutions - Amundi Index Equity Global Multi Smart Allocation Scientific Beta AE-C EUR | 23/04/2024 |
|
|
Top 5 Holdings | Sector | % |
Merck & Co Inc | Healthcare | 0.88 |
Vertex Pharmaceuticals Inc | Healthcare | 0.64 |
Spotify Technology SA | Communication Services | 0.59 |
Meta Platforms Inc Class A | Communication Services | 0.54 |
Regeneron Pharmaceuticals Inc | Healthcare | 0.50 |
Increase Decrease New since last portfolio | ||
Amundi Index Solutions - Amundi Index Equity Global Multi Smart Allocation Scientific Beta AE-C EUR |